⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Neuromyelitis Optica Spectrum Disorder Market Poised for Robust Expansion Through 2036 | DelveInsight
prnewswire.com
AZN
Tezspire (AstraZeneca, Amgen) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
AZN
AMGN
Saphnelo (AstraZeneca) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
AZN
Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight USA - English USA - español USA - Deutsch
prnewswire.com
NVS
LLY
AZN
decision44 to Define the Next Era of AI-Powered Supply Chain Execution
prnewswire.com
ANF
ALC
AZN
ETN
F
CEVA
Orthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence
globenewswire.com
PFE
AZN
GILD
Ipsen appoints Michelle C. Werner as EVP, President of North America
globenewswire.com
BMY
AZN
NVS
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
prnewswire.com
GILD
INCY
BIIB
NVS
AMGN
JNJ
ABBV
BMY
AZN
MRK
PFE
TGTX
XNCR
CABA
IMUX
ZNTL
GLPG
CLNN
AUTL
Checkpoint Inhibitor Refractory Cancer Drugs Market to Reach USD 95,548.35 Million by 2032 Amid Rising Post-Checkpoint Inhibitor Sequencing Demand and Combination Treatment Adoption - Credence Research
prnewswire.com
BMY
MRK
REGN
EXEL
AZN
GSK
Jacobio Announces 2025 Annual Results
prnewswire.com
AZN